Skip to content

Effect of Ayurvedic formulations in pain during menstruation

Clinical evaluation of the effect of Sapthasara Kashaya and Saraswatharishta in Kashtarthava (Primary dysmenorrhoea)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006601
Enrollment
100
Registered
2016-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of primary dysmenorrhoea having painful menstruation for atleast three consecutive cycles with regular menstrual cycles having normal bleeding phase

Interventions

Intervention1: 1) Saptasara kshaya(Classical Ayurvedic formulation) 2) Saraswatharista (Classical Ayurvedic formulation): 1) Saptasara kshaya-Dose-20 ML twice daily, Dosage form-liq

Sponsors

Central Council for Research in Ayurvedic sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Painful menstruations for atleast three consecutive cycles with regular menstrual cycles having normal bleeding phases (21-35 is the normal menstrual cycle) 2) Not associated with any organic reproductive system abnormalities (excluded clinically and radiologically)

Exclusion criteria

Exclusion criteria: 1) Cases of secondary dysmenorrhoea 2) Abdominal pain associated with excessive vaginal bleeding 3) Associated with leiomyoma of uterus 4) Ovarian cysts endometriosis (radiologically conformed USG (ultra sonography)) 5) Associated with pelvic inflammatory diseases (PID Hydrosalpinx) 6) Associated with any serious systemic disorders likely to influenze menstrual cycles 7) History of malignancy of pelvic organs 8) History of hypo and hyper thyroidism 9) Women using an IUD/oral contraceptive pills (OCP) 10) Diabetes mellitus 11) Hypertension

Design outcomes

Primary

MeasureTime frame
Management of pain in the patients of primary dysmenorrhoeaTimepoint: Baseline 90 days and 180 days

Secondary

MeasureTime frame
1 Assessment of quality of life using SF-36 2 Evaluation of menstrual distress using menstrual distress questionnarTimepoint: Base line 90 days and 180 days

Countries

India

Contacts

Public ContactDr Sarada Ota

Central Council for Research in Ayurvedic Sciences

sarada_ota@yahoo.com9810425662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026